Durect Corporation, a specialty pharmaceutical company, engages in the development of pharmaceutical products based on its proprietary drug delivery technology platforms. The company's pharmaceutical systems enable optimized therapy for a given disease or patient population by controlling the rate and duration of drug administration. Durect was spun out of Alza in 1998.

Acquired Companies: LACTEL Absorbable Polymers, Southern BioSystems, IntraEAR, Inc.